Capital Analysts LLC Boosts Stock Position in The Cigna Group (NYSE:CI)

Capital Analysts LLC boosted its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 9.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,371 shares of the health services provider's stock after acquiring an additional 1,088 shares during the period. Capital Analysts LLC's holdings in The Cigna Group were worth $3,416,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of CI. TCTC Holdings LLC acquired a new stake in The Cigna Group during the fourth quarter worth about $25,000. Collier Financial bought a new position in shares of The Cigna Group during the fourth quarter valued at approximately $32,000. ORG Wealth Partners LLC acquired a new stake in shares of The Cigna Group in the 4th quarter worth about $34,000. Compagnie Lombard Odier SCmA bought a new position in shares of The Cigna Group in the fourth quarter worth $37,000. Finally, Transce3nd LLC acquired a new stake in shares of The Cigna Group in the 4th quarter worth approximately $38,000. Institutional investors and hedge funds own 86.99% of the company's stock.

The Cigna Group Trading Down 0.9 %

Shares of CI stock traded down $2.96 during mid-day trading on Friday, reaching $332.22. The company's stock had a trading volume of 1,187,390 shares, compared to its average volume of 1,702,592. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83. The company's 50 day simple moving average is $322.82 and its 200-day simple moving average is $310.34. The firm has a market capitalization of $90.92 billion, a PE ratio of 27.15, a price-to-earnings-growth ratio of 0.98 and a beta of 0.51.

The Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping the consensus estimate of $6.35 by $0.39. The business had revenue of $65.45 billion during the quarter, compared to analyst estimates of $60.39 billion. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The company's quarterly revenue was up 14.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.47 earnings per share. On average, research analysts predict that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd will be given a $1.51 dividend. The ex-dividend date of this dividend is Tuesday, June 3rd. This represents a $6.04 annualized dividend and a dividend yield of 1.82%. The Cigna Group's dividend payout ratio is 49.35%.

Insiders Place Their Bets

In related news, insider Noelle K. Eder sold 9,944 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $320.00, for a total value of $3,182,080.00. Following the completion of the transaction, the insider now owns 13,406 shares of the company's stock, valued at $4,289,920. The trade was a 42.59 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Elder Granger sold 2,376 shares of the business's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $310.35, for a total value of $737,391.60. Following the sale, the director now owns 5,471 shares in the company, valued at approximately $1,697,924.85. This trade represents a 30.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 43,751 shares of company stock worth $13,603,991. 0.70% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Wells Fargo & Company decreased their price target on shares of The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a research report on Tuesday, February 4th. StockNews.com upgraded The Cigna Group from a "buy" rating to a "strong-buy" rating in a report on Tuesday, April 8th. UBS Group lowered their price objective on shares of The Cigna Group from $410.00 to $390.00 and set a "buy" rating on the stock in a research note on Monday, February 3rd. Royal Bank of Canada set a $355.00 target price on The Cigna Group in a research report on Friday, January 31st. Finally, Raymond James reaffirmed a "strong-buy" rating and set a $360.00 price objective (down previously from $415.00) on shares of The Cigna Group in a report on Friday, January 31st. Two analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have given a strong buy rating to the company's stock. According to MarketBeat, The Cigna Group currently has a consensus rating of "Buy" and an average price target of $373.56.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.